BioSpace News Archive

BBK Worldwide (BBK), an industry leader in the clinical trial patient experience and engagement technologies, releases key performance metrics on its concierge services, revealing the significant impact these site- and patient-centric programs have on global clinical trial recruitment and engagement.

EU patent bolsters the Company’s IP portfolio for future expansion opportunity into European market where 6 million colonoscopies are performed annually

The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced that Novartis will have access to commercially develop their therapeutic, biomaterial-based, cancer vaccine technology that promotes anti-cancer immunity.

Essity has today published its Annual and Sustainability Report for 2017, available on www.essity.com.

SRF231 is a fully human antibody that inhibits the activity of CD47, a protein overexpressed on many types of cancer cells which prevents them from being engulfed and eliminated by macrophages.

Mitomycin for Injection is available to Mylan’s hospital and other institutional customers.

Brammer Bio announces recent leadership appointments to support the growth of the organization.

Oxford Nanopore Technologies Ltd has raised £100M ($140M) in new investment.

Supplemental Health Care is proud to earn the “Best Place to Work” award in the large-sized company category by Buffalo Business First, a leading business publication in the region.

Relocation Saves $65,000 Per Month and Eliminates $14 Million Long-Term Liability